Secukinumab: A New Treatment Option for Psoriatic Arthritis
about
Psoriasis and Psoriatic Arthritis.Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders.Secukinumab: A Review in Psoriatic Arthritis.IL-23 and Th17 Disease in Inflammatory ArthritisA Review of the Use of Secukinumab for Psoriatic Arthritis.Current perspectives on biological approaches for osteoarthritis.Clinical Features of Psoriatic Arthritis: a Comprehensive Review of Unmet Clinical Needs.Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3).Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition.Influence of TNF and IL17 Gene Polymorphisms on the Spondyloarthritis Immunopathogenesis, Regardless of HLA-B27, in a Brazilian Population.Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison.Enthesitis: Much More Than Focal Insertion Point Inflammation.
P2860
Q37723047-6AB51C82-279C-408F-AEF0-D44010C1DA17Q38632657-5A19DFD2-E83A-455B-9FEB-A59635BBC2F0Q38864743-4BE93FFA-0406-4F76-973B-6E8B29BDAAA2Q41674783-9194A915-B27D-4A2B-8E01-84A76C11B47EQ47160133-C913BC16-982F-4536-A686-C30871A4C5FBQ47229491-14957C0A-8A93-4538-B01E-3CA3A05F6028Q48339070-C10D6BFA-5D02-4833-A145-C819976C6F4CQ52653700-E48F74FA-D05D-48FE-8BF2-86BAA314F702Q53828883-68A9CF98-16E8-40FF-9469-769339EAA7E0Q54966906-4E376AED-3CFC-4D97-92D1-5E135A1E861CQ54978927-9A45CC49-0386-4ECF-B071-D2F9D2D005A3Q55119878-E60B67D3-3C0C-4C4C-BE34-C116E8728E3F
P2860
Secukinumab: A New Treatment Option for Psoriatic Arthritis
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Secukinumab: A New Treatment Option for Psoriatic Arthritis
@ast
Secukinumab: A New Treatment Option for Psoriatic Arthritis
@en
Secukinumab: A New Treatment Option for Psoriatic Arthritis
@nl
type
label
Secukinumab: A New Treatment Option for Psoriatic Arthritis
@ast
Secukinumab: A New Treatment Option for Psoriatic Arthritis
@en
Secukinumab: A New Treatment Option for Psoriatic Arthritis
@nl
prefLabel
Secukinumab: A New Treatment Option for Psoriatic Arthritis
@ast
Secukinumab: A New Treatment Option for Psoriatic Arthritis
@en
Secukinumab: A New Treatment Option for Psoriatic Arthritis
@nl
P2860
P3181
P1476
Secukinumab: A New Treatment Option for Psoriatic Arthritis
@en
P2093
Iain B. McInnes
Philip Mease
P2860
P2888
P3181
P356
10.1007/S40744-016-0031-5
P407
P577
2016-06-01T00:00:00Z
P6179
1010118954